TP53 and cancer: Similarly, cancer drugs that induce mitotic catastrophe, disruptively intercalate DNA or affect genes such as TP53 that help regulate chromosomal stability could directly target tumour heterogeneity and hinder the synergistic interactions of social heterosis [156].